Palifermin for management of treatment-induced oral mucositis in cancer patients

References

• Raber-DurlacherJEBaraschAPetersonDEOral complications and management considerations in patients treated with high-dose cancer chemotherapySupport Cancer Ther2004421923018628146
   PubMedGoogle Scholar
• SonisSTThe pathobiology of mucositisNat Rev Cancer2004427728415057287
   PubMed Web of Science ®Google Scholar
• BaraschAPetersonDERisk factors for ulcerative oral mucositis in cancer patients: unanswered questionsOral Oncol2003399110012509961
   PubMed Web of Science ®Google Scholar
• SonisSTOsterGFuchsHOral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantationJ Cli Oncol20011922012205
   PubMed Web of Science ®Google Scholar
• RubinJSBottaroDPChedidMKeratinocyte growth factorCell Biol Int1995193994117640656
   PubMed Web of Science ®Google Scholar
• MacDonaldKPHillGRKeratinocyte growth factor (KGF) in hematology and oncologyCurr Pharm Des2002839540312069377
   PubMed Web of Science ®Google Scholar
• McKeownSTHylandPLLockeMMackenzieICIrwinCRKeratinocyte growth factor and scatter factor expression by regionally defined oral fibroblastsEur J Oral Sci2003111425012558807
   PubMed Web of Science ®Google Scholar
• JeschkeMGRichterGHofstadterFHerndonDNPerez-PoloJRJauchKWNon-viral liposomal Keratinocyte growth factor (KGF) cDNA gene transfer improves dermal and epidermal regeneration through stimulation of epithelial and mesenchymal factorsGene Ther200291065107412140734
   PubMed Web of Science ®Google Scholar
• FarrellCLBreadyJVRexKLKeratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortalityCancer Res1998589339399500453
   PubMed Web of Science ®Google Scholar
• FarrellCLRexKLChenJNThe effects of keratinocyte growth factor inpreclinical models of mucositisCell Prolif200235Suppl 1788512139710
   PubMed Web of Science ®Google Scholar
• NingSShuiCKhanWBeffects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivoInt J Rad Oncol Biol Phys199840177187
   PubMed Web of Science ®Google Scholar
• FarrellCLRexKLKaufmanSAEffects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated miceInt J Radiat Biol19997560962010374943
   PubMed Web of Science ®Google Scholar
• PottenCSBoothDCraggNJCell kinetic studies in the murine ventral tongue epithelium: mucositis induced by radiation and its protection by pretreatment with keratinocyte growth factor (KGF)Cell Prolif200235 suppl 1324712139706
   PubMed Web of Science ®Google Scholar
• DorrWNoackRSpeklKFarrellCLModification of oral mucositis by keratinocyte growth factor: single radiation exposureInt J Radiat Biol20017734134711258848
   PubMed Web of Science ®Google Scholar
• DorrWSpeklKFarrellCLThe effect of keratinocyte growth factor on healing of manifest radiation ulcers in mouse tongue epitheliumCell Prolif200235 suppl 1869212139711
   PubMed Web of Science ®Google Scholar
• Panoskaltsis-MortariATaylorPARubinJSKeratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injuryBlood2000964350435611110712
   PubMed Web of Science ®Google Scholar
• SeggwissRLoreKGuenagaFJKeratinocyte growth factor auguments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus monkeysBlood200711044144917374737
   PubMed Web of Science ®Google Scholar
• LombaertIMBrunstingJFWierengaPKKampingaHHde HaanGCoppesRPKeratinocyte growth factor prevents radiationdamage to salivary glands by expansion of the stem/progenitor poolStem Cells2008262595260118669914
   PubMed Web of Science ®Google Scholar
• NguyenTNZangXPPentoJTKeratinocyte growth factor stimulates the migration and proliferation of breast cancer cells in a culture wounding modelPharmacol Res20024617918312220958
   PubMed Web of Science ®Google Scholar
• ZangXPNguyenTNPentoJTSpecific and non-specific KGF-induced breast cancer cell motilityAnticancer Res2002222539254512529961
   PubMed Web of Science ®Google Scholar
• TaniguchiFHaradaTSakamotoYActivation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cellsJ Clin Endocrinol Metab20038877378012574212
   PubMed Web of Science ®Google Scholar
• RotoloSCeccarelliSRomanoFFratiLMarcheseCAngeloniASilencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy in responsive cancer cellsPLoS ONE20083e252818575591
   PubMed Web of Science ®Google Scholar
• BrakeRStarnesCLuJeffects of palifermin on antitumor activity of chemotherapeutic and biological agents in human head and neck and colorectal carcinoma xenograft modelsMol Cancer Res200861337134618708365
   PubMed Web of Science ®Google Scholar
• GibsonRJKeefeDMClarkeJMThe effect of keratinocyte growth factor on tumor growth and small intestinal mucositis after chemotherapy in the rat with breast cancerCancer Chemother Pharmacol200250535812111112
   PubMed Web of Science ®Google Scholar
• BrizelDMHermanTGoffinetDA phase I/II trial of escalating doses of recombinant human keratinocyte growth factor (rHuKGF) in head and neck cancer (HNC) patients receiving radiotherapy (RT) with concurrent chemotherapy (CCT). (Abstr)Int J Radiat Oncol Biol Phys200151 suppl 140
   Google Scholar
• BrizelDMMurphyBARosenthalDIPhase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinomaJ Clin Oncol2008262489249618487568
   PubMed Web of Science ®Google Scholar
• MeropolNJsomerRAGutheilJRandomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectantJ Clin Oncol2003211452145812697866
   PubMed Web of Science ®Google Scholar
• SpielbergerRTStiffPEmmanouilidesCEfficacy of recombinant human keratinocyte growth factor (rHuKGF) in reducing mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation (auto-PBPCT) after radiation-based conditioning: results of a phase 2 trial [Abstract]Proc Am Soc Clin Oncol2001207a
   Web of Science ®Google Scholar
• SpielbergerRStiffPBensingerWPalifermin for oral mucositis after intensive therapy for hematologic cancersN Engl J Med20043512590259815602019
   PubMed Web of Science ®Google Scholar
• HorsleyPBauerJDMazkowiackRGardnerRBashfordJPalifermin improves severe mucositis, swallowing problems, nutrition impact symptoms, and length of stay in patients undergoing hematopoietic stem cell transplantationSupport Care Cancer20071510510916896881
   PubMed Web of Science ®Google Scholar
• RosenLSAbdiEDavisIDPalifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapyJ Clin Oncol2006245194520017075109
   PubMed Web of Science ®Google Scholar
• SchmidtEThoennissenNHRudatAUse of palifermin for the prevention of high-dose methotrexate-induced oral mucositisAnn Oncol2008191644164918453519
   PubMed Web of Science ®Google Scholar
• EltingLSShihYCStiffPJEconomic impact of palifermin on the cost of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial resultsBiol Blood Marrow Transplant20071380681317580258
   PubMed Web of Science ®Google Scholar
• LangnerSStaberPSchubNPalifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipientsBone Marrow Transplant20084227527918500368
   PubMed Web of Science ®Google Scholar
• LevineJEBlazarBRDeForTFerraraJLWeisdorfDJLong-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT)Biol Blood Marrow Transplant2008141017102118721764
   PubMed Web of Science ®Google Scholar
• Nasilowska-AdamskaBRzepeckiPMankoJThe influence of palifermin (Kepivance) on oral mucoasitis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplantBone Marrow Transplant20074098393817846600
   PubMed Web of Science ®Google Scholar
• AldersonRGohari-FritschSOlsenHRoschkeVVanceCConnollyPIn vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cellsCancer Chemother Pharmacol20025020221212203102
   PubMed Web of Science ®Google Scholar
• FreytesCORatanatharathornVTaylorCPhase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantationClin Cancer Res2004108318832415623608
   PubMed Web of Science ®Google Scholar
• AlvarezEFeyEGValaxPPreclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositisClin Cancer Res200393454346112960137
   PubMed Web of Science ®Google Scholar
• AlvarezEGerlachVLGerwienRWsingle-dose prevention or short-term treatment with fibroblast growth factor-20 (CG53135-05) reduces the severity and duration of oral mucositisSupport Cancer Ther2005212212718628199
   PubMedGoogle Scholar
• ShusterMWShoreTBHarpelJGSafety and tolerability of velafermin (CG53135–05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantSupport Care Cancer20081647748317710442
   PubMed Web of Science ®Google Scholar